-
1
-
-
6344272219
-
Controversy in the management of retinal venous occlusive disease
-
Bearelly S., and Fekrat S. Controversy in the management of retinal venous occlusive disease. Int Ophthalmol Clin 44 (2004) 85-102
-
(2004)
Int Ophthalmol Clin
, vol.44
, pp. 85-102
-
-
Bearelly, S.1
Fekrat, S.2
-
2
-
-
0031001942
-
Natural history and clinical management of central retinal vein occlusion
-
CVOS Study Group
-
CVOS Study Group. Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol 115 (1997) 486-491
-
(1997)
Arch Ophthalmol
, vol.115
, pp. 486-491
-
-
-
3
-
-
26844569739
-
Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion
-
Cekic O., Chang S., Tseng J., et al. Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion. Retina 25 (2005) 846-850
-
(2005)
Retina
, vol.25
, pp. 846-850
-
-
Cekic, O.1
Chang, S.2
Tseng, J.3
-
4
-
-
3543128941
-
Intravitreal triamcinolone for the management of macular edema due to nonischemic central retinal vein occlusion
-
Bashshur Z., Ma'luf R.N., Allam S., et al. Intravitreal triamcinolone for the management of macular edema due to nonischemic central retinal vein occlusion. Arch Ophthalmol 122 (2004) 1137-1140
-
(2004)
Arch Ophthalmol
, vol.122
, pp. 1137-1140
-
-
Bashshur, Z.1
Ma'luf, R.N.2
Allam, S.3
-
5
-
-
0041670785
-
Morphological and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion
-
Degenring R., Kamppeter B., Kreissig I., et al. Morphological and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion. Acta Ophthalmol Scand 81 (2003) 548-550
-
(2003)
Acta Ophthalmol Scand
, vol.81
, pp. 548-550
-
-
Degenring, R.1
Kamppeter, B.2
Kreissig, I.3
-
6
-
-
3543147844
-
Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion
-
Ip M., Gottlieb J.L., Kahana A., et al. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. Arch Ophthalmol 122 (2004) 1131-1136
-
(2004)
Arch Ophthalmol
, vol.122
, pp. 1131-1136
-
-
Ip, M.1
Gottlieb, J.L.2
Kahana, A.3
-
7
-
-
29244448689
-
Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular disease
-
Jonas J. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular disease. Acta Ophthalmol Scand 83 (2005) 645-663
-
(2005)
Acta Ophthalmol Scand
, vol.83
, pp. 645-663
-
-
Jonas, J.1
-
8
-
-
21944444230
-
Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases
-
Jonas J., Kreissig I., and Degenring R. Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases. Prog Retin Eye Res 24 (2005) 587-611
-
(2005)
Prog Retin Eye Res
, vol.24
, pp. 587-611
-
-
Jonas, J.1
Kreissig, I.2
Degenring, R.3
-
9
-
-
0036946710
-
Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion
-
Jonas J.B. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 240 (2002) 782-783
-
(2002)
Graefes Arch Clin Exp Ophthalmol
, vol.240
, pp. 782-783
-
-
Jonas, J.B.1
-
10
-
-
14744276534
-
Intravitreal triamcinolone acetonide in patients with macular oedema due to central vein occlusion
-
Krepler K., Ergun E., Sacu S., et al. Intravitreal triamcinolone acetonide in patients with macular oedema due to central vein occlusion. Acta Ophthalmol Scand 83 (2005) 71-75
-
(2005)
Acta Ophthalmol Scand
, vol.83
, pp. 71-75
-
-
Krepler, K.1
Ergun, E.2
Sacu, S.3
-
11
-
-
0041826878
-
Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion
-
Park C.H., Jaffe G.J., and Fekrat S. Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. Am J Ophthalmol 136 (2003) 419-425
-
(2003)
Am J Ophthalmol
, vol.136
, pp. 419-425
-
-
Park, C.H.1
Jaffe, G.J.2
Fekrat, S.3
-
12
-
-
18144402778
-
Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion
-
Williamson T.H., and O'Donnell A. Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion. Am J Ophthalmol 139 (2005) 860-866
-
(2005)
Am J Ophthalmol
, vol.139
, pp. 860-866
-
-
Williamson, T.H.1
O'Donnell, A.2
-
13
-
-
37349107798
-
Intravitreal bevacizumab injections for treatment of central retinal vein occlusion
-
Priglinger S.G., Wolf A.H., Kreutzer T.C., Kook D., et al. Intravitreal bevacizumab injections for treatment of central retinal vein occlusion. Retina 27 (2007) 1004-1012
-
(2007)
Retina
, vol.27
, pp. 1004-1012
-
-
Priglinger, S.G.1
Wolf, A.H.2
Kreutzer, T.C.3
Kook, D.4
-
14
-
-
0141499061
-
Noninfectious endophthalmitis associated with intravitreal triamcinolone injection
-
Roth D.B., Chieh J., Spirn M.J., et al. Noninfectious endophthalmitis associated with intravitreal triamcinolone injection. Arch of Ophthalmol 121 (2003) 279-282
-
(2003)
Arch of Ophthalmol
, vol.121
, pp. 279-282
-
-
Roth, D.B.1
Chieh, J.2
Spirn, M.J.3
-
16
-
-
0033761752
-
Fluocinolone acetonide sustained drug delivery device to treat severe uveitis
-
Jaffe G.J., Ben-nun J., Gou H., et al. Fluocinolone acetonide sustained drug delivery device to treat severe uveitis. Ophthalmology 107 (2000) 2024-2033
-
(2000)
Ophthalmology
, vol.107
, pp. 2024-2033
-
-
Jaffe, G.J.1
Ben-nun, J.2
Gou, H.3
-
17
-
-
21444461055
-
Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis
-
Jaffe G.J., McCallum R.M., Branchaud B., et al. Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis. Ophthalmology 112 (2005) 1192-1198
-
(2005)
Ophthalmology
, vol.112
, pp. 1192-1198
-
-
Jaffe, G.J.1
McCallum, R.M.2
Branchaud, B.3
-
18
-
-
33646925637
-
Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis
-
Jaffe G.J., Martin D., Callanan D., et al. Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis. Ophthalmology 113 (2006) 1020-1027
-
(2006)
Ophthalmology
, vol.113
, pp. 1020-1027
-
-
Jaffe, G.J.1
Martin, D.2
Callanan, D.3
-
19
-
-
33947275043
-
Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema
-
Kupperman B.D., Blumenkranz M.S., Haller J.A., et al. Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema. Arch Ophthalmol 125 (2007) 309-317
-
(2007)
Arch Ophthalmol
, vol.125
, pp. 309-317
-
-
Kupperman, B.D.1
Blumenkranz, M.S.2
Haller, J.A.3
-
20
-
-
1842556483
-
Intractable glaucoma following intravitreal triamcinolone in central retinal vein occlusion
-
Kaushik S., Gupta V., Gupta A., Dogra M.R., and Singh R. Intractable glaucoma following intravitreal triamcinolone in central retinal vein occlusion. Am J Ophthalmol 137 (2004) 758-760
-
(2004)
Am J Ophthalmol
, vol.137
, pp. 758-760
-
-
Kaushik, S.1
Gupta, V.2
Gupta, A.3
Dogra, M.R.4
Singh, R.5
-
21
-
-
34548156523
-
Clinical pseudophakic cystoid macular edema. Risk factors for development and duration after treatment
-
Henderson B.A., Kim J.Y., Ament C.S., Ferrufino-Ponce Z.K., Grabowska A., and Cremers S.L. Clinical pseudophakic cystoid macular edema. Risk factors for development and duration after treatment. J Cataract Refract Surg 33 (2007) 1550-1558
-
(2007)
J Cataract Refract Surg
, vol.33
, pp. 1550-1558
-
-
Henderson, B.A.1
Kim, J.Y.2
Ament, C.S.3
Ferrufino-Ponce, Z.K.4
Grabowska, A.5
Cremers, S.L.6
|